Pharmacosmos Therapeutics Inc.

NJ · United States · Reporting entity ID 100000801827

Total reported 2019–2025

$5.12M

#698 of 2,960 reporting companies — 0% of all reported industry payments

$4.83M in general payments across 24,360 records, plus $293K in research funding across 98 records.

How it breaks down

General payments $4,826,085

Research funding $292,674

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.